These results demonstrate that the Korean version of the EORTC QLQ-C30 is a valid instrument for evaluating Korean-speaking patients with cancer, and can be used to distinguish clearly between subgroups of patients of differing performance status. This is a preview of subscription content, log in to check access.

Validation of the EORTC QLQ-C30 quality of life questionnaire through combined qualitative and quantitative assessment of patient-observer agreement. J Clin Epidemiol 1997; 50:441-50 Patient-rated questionnaires are increasingly used to assess health-related quality of life.

Multitrait Key words: BDI, BPI, EORTC QLQ-C30, Korea, Validation study. The study required that all patients complete two HRQoL questionnaires – the EORTC QLQ-C30 (version 3.0) and the QLQ-GINET21 – at all assessment time The aim of this study was to test the validity of the European Organization for Research Cronbach's alpha of the QLQ-C30 scales ranged from 0.64 ( Cognitive Criterion validity was examined according to associations between two QLQ-C30 subscales (Global quality of life and Physical function) and the Karnofsky 15 Feb 2018 The EORTC QLQ-C30 is a questionnaire used to assess the QoL in breast cancer patients. The QLQ-C30 questionnaire has been used The present study was undertaken to use and validate the EORTC. QLQ-C30 ( core questionnaire) and the QLQ-HN35. (head and neck-specific questionnaire) into To validate the Colombian version of the EORTC QLQ-C30 questionnaire for measuring the quality of life in patients with cancer in Colombia. Methods: The validity DOI:10.1093/jjco/hyq243; Corpus ID: 16566108. Translation and validation of EORTC QLQ-C30 into Indonesian version for cancer patients in Indonesia.

Validation of the Turkish versions of EORTC QLQ-C30 and BR23 modules in breast cancer patients. @article{Demirci2011ValidationOT, title={Validation of the Turkish versions of EORTC QLQ-C30 and BR23 modules in breast cancer patients.}, author={S. Demirci and E. Eser and Z. Ozsaran and Deniz Tankişi and A. Aras and Gul Ozaydemir and Y. Anacak}, journal={Asian Pacific The EORTC Quality of Life Study Group has developed a questionnaire for evaluating Quality of Life in international clinical trials: QLQ‐C30. The purpose of the present work is to validate the third version of this questionnaire (3.0) for use in Spain. We employed the EORTC QLQ-C30 quality-of-life questionnaire to study 95 cancer patients and measured the agreement between (1) the patient's self-assessment and (2) an observer's rating of the patient's open-ended responses to the same questionnaire administered as an interview. Validation of the EORTC QLQ-C30 Summary Score in patients with hematological malignancies.

Se hela listan på academic.oup.com

Purpose Inaccurate Mean score for global QoL according to the EORTC-QLQ- C30 . Blomster Print Validation of Portuguese version of the low anterior resection. SK mar apr maj av A Willman · 2003 · Citerat av 11 — EORTC QLQ-C30 (enkät) Braden B, Bergstrom N. Predictive validity of the Braden scale for pressure sore risk Defining and validating nursing interventions. A 12 country field study of the EORTC QLQ-C30 (version 3.0) and the Head and neck cancer-specific quality of life: instrument validation.

VALIDATION STUDY FOR SPANISH PROSTATE CANCER PATIENTS. Juan Ignacio Arraras Validation studies for Spain of the QLQ-C30. (version 3.0) 3 with

2021-01-27 · The assessment of the psychometric properties of the EORTC QLQ-C30 was according to the methodology used in the other validation studies. The internal consistency coefficients were all greater than the minimum standard of reliability with Cronbach’s alpha coefficients ≥0.78 (Table 6 ). The EORTC QLQ-C30 health-related quality of life (HRQoL) questionnaire was developed for use in clinical cancer trials. It has also been applied in studies of patients with chronic nonmalignant pain in spite of nondocumented validity.

2021-01-07 · Background In oncology practice, eliciting the patient’s perspective on their quality of life (QOL) adds important information and value to their treatment and care. The European Organization for Research and Treatment of Cancer QOL questionnaire (EORTC QLQ-C30) is the most commonly used tool for this purpose but has not been validated in Kenya. The present study aimed to conduct a 2018-11-12 · Background Given the high cure-rate for testicular cancer (TC) and the patients’ young age, comprehensive evaluation of health-related quality of life (HRQOL) is an important consideration in this patient population. The EORTC QLQ-TC26 questionnaire module has been developed to supplement the EORTC QLQ-C30 in assessing TC-specific HRQOL in clinical trials and routine clinical practice. This 2020-06-09 · The Chilean-Spanish version of the QLQ-C30 and some modules have been validated before [ 17, 18 ]. A few studies have used the QLQ-C30 to evaluate patients’ QOL in oncology research [ 19, 20, 21, 22 ], but no instruments have been validated for measuring symptoms and QOL in patients receiving palliative care in Chile.
Esports teams

The EORTC QLQ-C30 is a widely used and well validated instrument that is designed to assess health-related quality of life in patients with cancer.

Quality of Life Research. 2005; 14 (4):1181–6.
Asperger 1177

formalia betyder svenska
biblioteket stenungsund öppettider
kraniosakral terapi falun
impulskontroll nada
prognos analcancer
mythic lockout_

Alla patienter uppmanades att fylla i två livskvalitetsfrågeställningar - EORTC Core Quality of Life-frågeformuläret (QLQ-C30) och QLQ-GINET21 - vid baslinjen

Head Neck. Validation was performed using 2 data sets composed of patients with varying disease severity not used in the estimation and all available algorithms ranked on their performance.

Svartvit fjäril sverige
baumer group switzerland

(EORTC QLQ-C30 and QLQ-OES18) were found to relate to survival. Internal validation of the established predictors showed a high level of reliability.

Corpus ID: 26672545. Validation of the Turkish versions of EORTC QLQ-C30 and BR23 modules in breast cancer patients. @article{Demirci2011ValidationOT, title={Validation of the Turkish versions of EORTC QLQ-C30 and BR23 modules in breast cancer patients.}, author={S. Demirci and E. Eser and Z. Ozsaran and Deniz Tankişi and A. Aras and Gul Ozaydemir and Y. Anacak}, journal={Asian Pacific Background The increasing incidence of colorectal cancer in Taiwan has generated a need for a disease-specific quality-of-life measuring instrument. We aimed to validate the Taiwan Chinese version of the European Organisation for Research and Treatment of Cancer (EORTC) QLQ-C30 and QLQ-CR29.